Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Proteasome
    (35)
  • Apoptosis
    (13)
  • Autophagy
    (11)
  • Endogenous Metabolite
    (3)
  • Antibiotic
    (2)
  • DUB
    (2)
  • NF-κB
    (2)
  • PROTACs
    (2)
  • Parasite
    (2)
  • Others
    (12)
Filter
Search Result
Results for "

20s proteasome

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    46
    TargetMol | All_Pathways
  • Peptide Products
    6
    TargetMol | Peptide_Products
  • Dye Reagents
    1
    TargetMol | All_Dye_Reagents
  • PROTAC Products
    2
    TargetMol | PROTAC
  • Natural Products
    7
    TargetMol | Natural_Products
  • Recombinant Protein
    2
    TargetMol | Recombinant_Protein
  • Isotope Products
    1
    TargetMol | Isotope_Products
  • Antibody Products
    6
    TargetMol | Antibody_Products
  • Disease Modeling
    1
    TargetMol | Disease_Modeling_Products
  • Reference Standards
    2
    TargetMol | Standard_Products
PROTAC 20S proteasome subunit β5 degrader 2
T200540
PROTAC 20S proteasome subunit β5 degrader 2 is a PROTAC degrader targeting the 20S proteasome subunit β5 (20Sproteasomesubunit β5), with a DC50 of 0.16 μM. It inhibits the proliferation of FaDu cancer cells, showcasing an IC50 of 0.23 μM. Additionally, PROTAC20Sproteasomesubunit β5 degrader 2 demonstrates antitumor activity in a mouse model.
  • Inquiry Price
Inquiry
Size
QTY
PROTAC 20S proteasome subunit β5 degrader 1
T200715
PROTAC 20S proteasome subunit β5 degrader 1 (compound 12f) serves as a targeted degrader of the 20S proteasome subunit β5, exhibiting a DC50 value of 0.11 μM in FaDu cells. This compound disrupts the cell cycle and promotes apoptosis (apoptosis), while inhibiting cell proliferation and migration in both FaDu and KM3/BTZ cells. It is applicable for research into resistance to Bortezomib in pharyngeal carcinoma and multiple myeloma.
  • Inquiry Price
Inquiry
Size
QTY